What The Activism World Is Talking AboutGuest Post
Trian Partners had long been expected to seek a board seat at Procter & Gamble, and yesterday’s announcement of its nomination of Nelson Peltz confirmed that objective. The activist still claims to want to avoid a proxy fight but as at DuPont two years ago, it will pull out all the stops to get Peltz in the boardroom, where he will establish a new route for information to reach directors, push for non-executive sessions . . .
This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here
If you are subscribed and having an account error please clear cache and then cookies if that does not work email firstname.lastname@example.org and we will get back to you as quick as humanly possible